Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. The Mount Sinai Physician’s Channel will show you some of the innovative procedures, new developments in patient care, and complex cases that are being performed in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field, and others.
Recently Added
Join Us at the Sixth International Prostate Cancer Symposium & World Congress of Urologic Oncology
December 11 - 14, 2024 The Mount Sinai Hospital New York, New York
Mount Sinai Adds a Rehab Component to Its Management of Pulmonary Disease
Mount Sinai Health System recently opened a comprehensive pulmonary rehabilitation program geared to patients with exercise limitations attributable to the lung or other organs. It offers them 8 to 12 weeks of muscle strengthening, helpful ...
Uncovering the Familial Link in Women with Postpartum Psychosis
A large cohort study from Mount Sinai provides evidence, for the first time, on familial risk of postpartum psychosis. The findings pave the way for preventive work that can be done for women at increased risk.
Exploring Links Between ‘Forever Chemicals’ and Thyroid Cancer
A group of per- and polyfluoroalkyl substances (PFAS)—endocrine-disrupting chemicals commonly dubbed "forever chemicals" due to their ability to persist in the environment—has long been thought to contribute to cancer risk. A Mount Sinai ...
Allergy, Immunology and Vaccinology | View More
Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver therapeutics into the brain, providing new ...
Expanded protocols promote early detection in high-risk patients and prevent hospital outbreaks of Candida auris.
Frontiers of Medical Research: Immunology
A new supplement to Science Magazine
How are advances in immunology transforming medical research and medical care? And how will these advances help to improve and prolong the lives of patients?
Mount Sinai scientists, in collaboration with researchers from the Carlos III Health Institute (ISCIII) in Madrid, Spain, have located and identified alterations in the monkeypox virus genome that potentially correlate with changes in ...
Cardiology & Cardiovascular Surgery | View More
Celebrating Dr. Valentín Fuster's Contributions to Cardiovascular Medicine and Science
JACC's Tribute Video Celebrates Valentín Fuster, MD at ACC.24
The specialized and complex Ross procedure is the optimal treatment for adolescents and adults with a diseased aortic valve, replacing it with the patient’s own pulmonary valve, resulting in improved long-term life expectancy and less ...
The new clinical trial, led by Valentín Fuster, MD, PhD, is responding to clinical evidence that the atherosclerotic process starts early in life, and even in young adults deemed otherwise healthy can pave the way for cardiovascular events.
Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes
Withdrawing aspirin one month after PCI in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared to dual antiplatelet therapy, the current standard of care.
CTMS: Center for Transgender Medicine & Surgery | View More
Mount Sinai’s Center for Transgender Medicine and Surgery provides care for transgender and gender-diverse people of all ages, with a focus on fertility preservation.
Updated Standards Provide Crucial Guidance for Health of Transgender and Gender Diverse People
Endocrinologists and other physicians gained important guidance, as the World Professional Association for Transgender Health released the first update of its standards of care in 10 years.
Mount Sinai Study Finds Testosterone Use in Transmasculine People Is Safer Than Previously Reported
Testosterone treatment for gender-affirming hormone therapy in transmasculine individuals often conjures up safety concerns among prescribing physicians, and patients and their families. However, the largest study of its type to date found ...
Shedding Light on Headache Disorders in Transgender and Gender-Diverse Adults and Youth
Learn about current best practices in the management of headache, and the latest research on the potential relationship between gender-affirming hormone therapy and headache.
Dermatology | View More
The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai is dedicated to delivering superior, comprehensive dermatologic care that exceeds patient expectations, and to advancing the science ...
Artificial Intelligence May Help Improve Melanoma and Skin Cancer Early Detection and Treatments
Artificial intelligence has enormous potential for diagnosing and treating melanoma and other skin cancers. When it comes to diagnosis, dermoscopy, confocal microscopy, optical coherence tomography, pathology, and whole-body imaging are ...
The research training program in Systems Skin Biology will take a multidisciplinary approach in teaching scientists to holistically understand human physiology, health, and disease.
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped.
Diabetes & Endocrinology | View More
Mount Sinai Endocrinologists Expand Diabetes Technology Use
Carol J. Levy, MD, and her team are working to expand the use of automated insulin delivery technology—studying its use in insulin-requiring people with type 2 diabetes and during pregnancies complicated by type 1 diabetes.
Mount Sinai Team Identifies Regions of DNA Associated With Excess Testosterone in PCOS
A team led by Andrea Dunaif, MD, has identified regions of DNA associated with testosterone production in women with polycystic ovary syndrome, bringing the field a step closer to determining the molecular causes of the condition.
A Combination Treatment, Including Harmine, Can Increase Human Insulin-Producing Cells in Vivo
Mount Sinai researchers have demonstrated that a two-drug combination to enable the regeneration of insulin-producing pancreatic beta cells for people with diabetes. One of the drugs, harmine, is a natural product found in plants.
A team from the Icahn School of Medicine at Mount Sinai has developed the most comprehensive epidemiological dataset for youth diabetes and prediabetes research, derived from extensive National Health and Nutrition Examination Survey (NHANES) ...
Gastroenterology, GI Surgery & Liver Diseases | View More
A Breakthrough UC Drug Is Approved Following a Rigorous Mount Sinai-Led Trial
The U.S. Food and Drug Administration has approved mirikizumab as a treatment for ulcerative colitis (UC) based on a pair of groundbreaking trials led by Mount Sinai’s gastroenterology team.
Obesity Drugs Among Those Being Examined for Efficacy Against NASH
Newly popular obesity drugs like Ozempic® and Wegovy® are among several undergoing clinical trials at Mount Sinai for nonalcoholic steatohepatitis, or NASH.
Protein Identified as Potential New Target for Treating Cholangiocarcinoma
A Mount Sinai researcher discovered that many patients with cholangiocarcinoma exhibit a highly elevated expression of B7-H4, a transmembrane protein that inhibits T cell immunity. This could offer a new immunotherapy target for bile duct ...
First-in-Class Therapy for Ulcerative Colitis Proves Effective in Clinical Trial
Tulisokibart, a monoclonal antibody designed specifically to bind to TL1A, a protein involved in the inflammatory process of ulcerative colitis, proved safe and effective in a phase 2 trial involving patients who had failed other therapies. ...
Genetics and Genomics | View More
Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver therapeutics into the brain, providing new ...
New Study Identifies Genetic Changes in Brain Development That May Contribute to Schizophrenia
A collaborative study between researchers at the Icahn School of Medicine at Mount Sinai and Harvard Medical School has identified genetic mutations that occur during brain development and may contribute to the development of schizophrenia.
The Unexpected Link between Parkinson’s Disease and the Gut
The laboratory of Inga Peter, PhD, Vice Chair of the Mount Sinai Department of Genetics and Genomic Sciences, has uncovered a surprising link between inflammatory bowel disease (IBD) and Parkinson’s disease.
At the Forefront of Genomics Technology
Mount Sinai’s Center for Advanced Genomics Technology (CAGT) offers the latest in sequencing tools, driving innovation in both basic and translational research that will impact clinical care.
Geriatrics | View More
Mount Sinai has begun embedding a dedicated palliative care team in the medical intensive care unit (MICU) at The Mount Sinai Hospital. Introducing palliative care earlier in the hospital admissions process, rather than waiting for ICU ...
New Research Shows Medicare Should Encourage Use of Hospice for People With Dementia
U.S. policymakers are increasingly focused on curtailing Medicare hospice services for people with dementia due to increasing hospice benefit expenditures. A new joint study by researchers at the Brookdale Department of Geriatrics and ...
Rethinking the Essential Role of Long-Term Home Care Workers
A new study by the Brookdale Department of Geriatrics and Palliative Medicine offers important insights into the critical role home care worker continuity plays in enabling older adults to successfully age in place.
Using Data to Improve the Quality of Palliative Care Across All Specialties
As medicine has become more complex and interdisciplinary, there has been an increased focus on using data to guide improvement of quality of care. One example is the work of Laura P. Gelfman, MD, Professor and Vice Chair, Quality and ...
Interventional Radiology | View More
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.
Transradial Balloon Occlusion Prostate Artery Embolization for BPH at Mount Sinai
Lower urinary tract symptoms had worsened in the months prior to the PAE
Mount Sinai Neurosurgery Chair, Joshua Bederson, MD Case Study: Brain Tumor Embolization
The benefits of preoperative embolization for treating meningiomas and other skull base tumors.
Prostatic Artery Embolization at Mount Sinai
Watch a PAE on a 74-year-old with a 20-year history of BPH.
Monkeypox
Mount Sinai scientists, in collaboration with researchers from the Carlos III Health Institute (ISCIII) in Madrid, Spain, have located and identified alterations in the monkeypox virus genome that potentially correlate with changes in ...
Curious About the Monkeypox Vaccine? Here’s What You Need to Know
Richard Silvera, MD, MPH of Mount Sinai details important information about monkeypox vaccination.
Neurology & Neurosurgery | View More
Mount Sinai, long a leader in epilepsy care and research, is expanding its partnerships with independent neurologists and primary care physicians across the United States, building on its expertise in new diagnostics and successful strategies ...
Mount Sinai Neurosurgery Chair, Joshua Bederson, MD Case Study: Brain Tumor Embolization
The benefits of preoperative embolization for treating meningiomas and other skull base tumors.
As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider
Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment ...
Mount Sinai Researchers Have Uncovered the Mechanism in the Brain That Constantly Refreshes Memory
Mount Sinai researchers have discovered for the first time a neural mechanism for memory integration that stretches across both time and personal experience.
Nuclear Medicine | View More
Learn more about advances in Nuclear Medicine and hear the amazing story of a patient treated at Mount Sinai’s Tisch Cancer Center.
This large study of patients undergoing PET MPI demonstrated that although reduced MBFR was more prevalent in women compared with men, there were no sex-specific differences in the prognostic value of reduced MBFR.
This study reviews the need for a separate risk threshold with PET and SPECT while selecting a high-risk population as the target for an intervention.
Use of anatomic testing such as coronary artery calcium scoring (CACS) of 0 to avoid myocardial perfusion imaging in symptomatic patients could lead to missing microvascular dysfunction in 4 out of 10 patients, a finding associated with a high mortality risk.
Obstetrics & Gynecology | View More
Mount Sinai Receives $3 Million Gift to Support Women’s Health Research
Four important areas across the lifespan—endometriosis, cervical cancer, preeclampsia, and menopause—are the focus of a $3 million gift from the Pershing Square Foundation to support women’s health research.
Obstetrics, Gynecology and Reproductive Science 2024
As a leader in Obstetrics, Gynecology and Reproductive Science, Mount Sinai meets a wide range of women's health care needs across the lifespan.
Register Today for the Second Annual Mount Sinai Women’s Health Forum
Wednesday, November 13, 2024 7:00 AM - 6:00 PM New York Academy of Medicine 1216 Fifth Avenue New York, NY 10029
Mount Sinai Health System has announced the launch of its Center of Excellence for Gynecologic Cancer, which is part of The Tisch Cancer Institute.
Occupational Medicine | View More
The event, held Tuesday, June 11, focused on sharing two decades of experience caring for 9/11 responders living with the enduring effects of exposure to psychological trauma and environmental toxins.
Meet the Mount Sinai Selikoff Centers for Occupational Health
The Mount Sinai Selikoff Centers for Occupational Health are widely recognized as leaders in the prevention, diagnosis, and treatment of workplace injuries and illnesses
Mount Sinai Experts Explain Medical Treatment Under Workers’ Compensation
At the Mount Sinai Selikoff Centers for Occupational Health, Workers' Compensation Coordinators are available to assist patients with filing New York State Workers' Compensation claims
Meet the Mount Sinai Selikoff Centers for Occupational Health: Mid-Hudson Valley
The Mount Sinai Selikoff Centers for Occupational Health are widely recognized as leaders in the prevention, diagnosis, and treatment of workplace injuries and illnesses
Oncology | View More
Mount Sinai’s Raja Flores, MD: New Standards in Lung Cancer Surgery
Raja Flores, MD, discusses nuanced approaches to surgical care for lung cancer, neoadjuvent chemotherapy, the role of randomized clinical trials, treatment for mesothelioma, and more
Breast Cancer Susceptibility Genes Figure in Screening for Pancreatic Cancer
Approximately 10 percent of pancreatic ductal adenocarcinoma is due to a hereditary or genetic predisposition, including variants in the breast and ovarian cancer syndrome genes BRCA1 and BRCA2.
Exploring Links Between ‘Forever Chemicals’ and Thyroid Cancer
A group of per- and polyfluoroalkyl substances (PFAS)—endocrine-disrupting chemicals commonly dubbed "forever chemicals" due to their ability to persist in the environment—has long been thought to contribute to cancer risk. A Mount Sinai ...
Mount Sinai Health System has announced the launch of its Center of Excellence for Gynecologic Cancer, which is part of The Tisch Cancer Institute.
Ophthalmology | View More
Uncovering Glaucoma’s Vascular Link in People of African Descent
Alon Harris, MS, PhD, FARVO, has committed 30 years of research to chipping away at the notion that intraocular pressure (IOP) is the predominant risk factor for openangle glaucoma (OAG), particularly in people of African descent.
Helping Low-Vision Patients Lead Independent Lives
For all their hard work to preserve and restore eyesight, ophthalmologists often reach the limits of what they can accomplish with standard treatment.
Intra-Arterial Chemotherapy Is a Game Changer for Patients With Retinoblastoma
New York Eye and Ear Infirmary of Mount Sinai is one of the few institutions in the New York metropolitan area to treat retinoblastoma, the most common type of eye cancer in young children.
Ophthalmology Specialty Report 2023
New York Eye and Ear Infirmary of Mount Sinai (NYEE) made significant strides in the fields of science and technology over the past year, particularly in the pursuit of cutting-edge approaches to early detection and treatment of diseases ...
Orthopedics | View More
Applying Novel Techniques to Preserve the Knee and Other Joints
When it comes to knee repairs, Mount Sinai’s sports medicine surgeons have one goal: reduce or eliminate the need for joint replacement.
Advancing Shoulder Arthroplasty With 3D Technology
Mount Sinai’s Leesa Galatz, MD, is embracing 3D-printed shoulder arthroplasty to create customized implants for each patient.
New Therapeutic Could Prevent Rotator Cuff Muscle Degeneration
Mount Sinai’s Woojin Han, PhD, is leading efforts to develop an injectable protein-releasing hydrogel patch that may prevent, and possibly reverse, rotator cuff muscle degeneration—a problem that could affect one-third of U.S. adults. ...
Mount Sinai Surgeon Aims to Optimize Outcomes for Patellofemoral Patients
Patellofemoral instability is a condition that often affects young female athletes. To better understand this population and identify best treatment practices, Mount Sinai’s Elizabeth R. Dennis, MD, MS, is participating in a multicenter ...
Otolaryngology/ENT | View More
The Mount Sinai Otolaryngology Surgical Video Series
The Mount Sinai Otolaryngology Surgical Video Series is a detailed, step-by-step instructional guide for surgeons and surgical trainees to learn standard approaches to ENT/Otolaryngology procedures.
Mount Sinai researchers have made breakthrough discoveries about the thyroid-stimulating hormone receptor that suggest new approaches to the treatment of autoimmune thyroid disease.
Microsurgical Training Has a New Look at the Buxton Microsurgical Education Center
The Jorge N. Buxton, MD, and Douglas F. Buxton, MD, Microsurgical Education Center is now home to the most modern high-definition microscopes that, along with a number of technological upgrades over the years, provide an unparalleled microsurgical ...
Mount Sinai Kravis Children's Hospital| View More
A Healthier Future for Every Child
Every day, Mount Sinai Kravis Children’s Hospital works to fulfill our mission of delivering innovative care, research, and education that equitably advances health for children and families.
Ahead of the Curve: Pediatric Advanced Diagnostic and Interventional Bronchoscopy
Interventional bronchoscopy has long been part of the adult pulmonologist's armamentarium; however, it is rarely used in children for a variety of reasons. But at Mount Sinai Kravis Children’s Hospital, interventional bronchoscopy has ...
Study findings could serve as a foundation for broader neuro-monitoring applications across intensive care units globally
Dr. Alfin Vicencio shares the “what”, “how” and “why” of Pediatric Advanced Diagnostic and Interventional Bronchoscopy
Psychiatry| View More
In June, Mount Sinai launched a comprehensive, state-of-the-art destination for integrated mental health, substance use, and primary care, with a commitment to fostering breakthrough clinical research: the Mount Sinai-Behavioral Health Center.
Continuing to Redefine Addiction Medicine Through Neuroimaging
A leader of neuroimaging and addiction science at Mount Sinai has discovered the impairment of a brain circuit pathway as a key driver in human drug addiction, extending previous findings in animal models. These findings hold potential ...
Uncovering the Familial Link in Women with Postpartum Psychosis
A large cohort study from Mount Sinai provides evidence, for the first time, on familial risk of postpartum psychosis. The findings pave the way for preventive work that can be done for women at increased risk.
Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver therapeutics into the brain, providing new ...
Pulmonology | View More
The Unusual Protective Properties of SARS-CoV-2 in People With Asthma
Mount Sinai researchers are exploring the finding that certain proteins produced by patients with mild to moderate eosinophilic asthma downregulate the angiotensin-converting enzyme 2 receptor that allows SARS-CoV-2 entry to airway cells, ...
Support Services at Mount Sinai Make a Difference for Patients With Lung Disease
To help patients with lung disease work through what can be a life-changing diagnosis, Mount Sinai provides holistic, compassionate care.
Mount Sinai Adds a Rehab Component to Its Management of Pulmonary Disease
Mount Sinai Health System recently opened a comprehensive pulmonary rehabilitation program geared to patients with exercise limitations attributable to the lung or other organs. It offers them 8 to 12 weeks of muscle strengthening, helpful ...
Expanded protocols promote early detection in high-risk patients and prevent hospital outbreaks of Candida auris.
Rehabilitation | View More
Online Spinal Cord Injury Programs Scale to New Heights Post-Pandemic
What started out as spinal cord injury programs going online out of necessity during the COVID pandemic gained traction over the years.
A New Facility for Rehabilitation Medicine and Human Performance
A long overdue revamp of the Department of Rehabilitation Medicine's inpatient unit is set to improve patient care, modernize equipment, as well as take education and research capabilities to new levels.
Mount Sinai Rehabilitation Physicians Featured in new Documentary film “Quad Gods”
See the official trailer for the Quad Gods documentary on HBO
Rehabilitation and Human Performance 2024
The Department of Rehabilitation and Human Performance at Mount Sinai has been dedicated to advancing human performance and solving barriers for those with disabilities since 1910.
Urology | View More
Significant Advances in Cancer Treatment and Research for the Department of Urology
Significant advances in patient care and research by the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai were recognized as the Department recorded a number of significant milestones in 2023 ...
An Important Milestone: Marking the 500th Robotic Cystectomy Surgery in the Bladder Cancer Program
A team at the Department of Urology recently performed the 500throbotic cystectomy in Mount Sinai’s Bladder Cancer Program, a significant milestone that underscores innovations in patient care, research, and clinical excellence that make ...
Join Us at the Sixth International Prostate Cancer Symposium & World Congress of Urologic Oncology
December 11 - 14, 2024 The Mount Sinai Hospital New York, New York
Rethinking the Role of Lymph Nodes in Prostate Cancer: A study from Mount Sinai
In this study, Ash Tewari, MD and additional authors at Mount Sinai suggest re-evaluating the common practice of removing lymph nodes during prostate cancer surgery, as it can be risky and may not provide therapeutic benefits.
Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. The Mount Sinai Physician’s Channel will show you some of the innovative procedures, new developments in patient care, and complex cases that are being performed in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field, and others.